Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has shared an announcement.
Daito Pharmaceutical Co., Ltd. has announced a partial correction to its initial financial results presentation for the first half of the fiscal year ending May 2025. The correction addresses inaccuracies found in the previously disclosed materials, with updates to be reflected on the company’s website, indicating a commitment to transparency and accuracy in financial reporting.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of medicinal drugs. It is a publicly traded company listed on the Prime Market of the Tokyo Stock Exchange.
YTD Price Performance: -0.67%
Average Trading Volume: 31,467
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen31.85B
For an in-depth examination of 4577 stock, go to TipRanks’ Stock Analysis page.